Financials
- Market Capitalization 1.66 B
- Employee 305
- Founded 2018
- CEO David Hung
- Website www.nuvationbio.com
- Headquarter Delaware, United States
- FIGI BBG00VHJ0CC1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-14.93
売上高対価格比率
0.05
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2060 | SEPN Septerna, Inc. - Common Stock | 36.42 USD | -3.04% | +3.29% | -7.84% | +65.47% | 1.70 B USD | ||
| 2070 | NTLA Intellia Therapeutics, Inc. - Common Stock | 11.91 USD | -5.33% | -1.65% | +1.36% | -13.19% | 1.67 B USD | ||
| 2084 | ZBIO Zenas BioPharma, Inc. - Common Stock | 25.16 USD | -4.70% | -6.43% | -21.52% | -4.91% | 1.64 B USD | ||
| 2112 | GPCR Structure Therapeutics Inc - American Depositary Shares | 22.31 USD | -6.69% | -17.80% | -41.84% | -16.57% | 1.59 B USD |